Patents by Inventor BRADLEY G. WOUTERS

BRADLEY G. WOUTERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220401438
    Abstract: Described herein are methods and compositions for screening cancer cells for sensitivity to itraconazole and use of itraconazole in treatment of cancer.
    Type: Application
    Filed: April 22, 2022
    Publication date: December 22, 2022
    Inventors: Anthony Michael JOSHUA, Marianne KORITZINSKY, Sue LI, Stefano MARASTONI, Bradley G. WOUTERS
  • Patent number: 10222380
    Abstract: A compound of formula (I) as described herein and methods and uses thereof as probes in the mass tagging of biosensors or biologically active materials for use in mass cytometry analysis of tissue samples such as in the detection, labelling and quantification of oxygen-deprived cells by using, for example, tellurophene-tagged 2-nitroimidazole.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: March 5, 2019
    Assignees: The Governing Council of the University of Toronto, University Health Network
    Inventors: Mark Nitz, Landon J. Edgar, Bradley G. Wouters, David Hedley, Lisa M. Willis, Matthew A. Lumba, Hanuel Park, Ravi N. Vellanki
  • Publication number: 20170269094
    Abstract: A compound of formula (I) as described herein and methods and uses thereof as probes in the mass tagging of biosensors or biologically active materials for use in mass cytometry analysis of tissue samples such as in the detection, labelling and quantification of oxygen-deprived cells by using, for example, tellurophene-tagged 2-nitroimidazole.
    Type: Application
    Filed: August 20, 2015
    Publication date: September 21, 2017
    Inventors: MARK NITZ, LANDON J. EDGAR, BRADLEY G. WOUTERS, DAVID HEDLEY, LISA M. WILLIS, MATTHEW A. LUMBA, HANUEL PARK, RAVI N. VELLANKI